Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $11.4B | $8,085.0M | $19.3B | $8,144.0M | $8,104.0M | $8,635.0M | $8,257.0M | $10.0B | $14.6B | $22.0B | $9,135.0M | $6,960.0M | $7,215.0M | $21.3B | $11.2B | $16.3B | $7,020.0M | $22.0B | $31.4B | $2,119.0M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Pfizer Inc.'s last 12-month Net Income is $4,260.0M, based on the financial report for Sep 29, 2024 (Q3 2024).
Over the last year, Pfizer Inc.'s Net Income growth was (59.3%). The average annual Net Income growth rates for Pfizer Inc. have been (27.4%) over the past three years, (23.5%) over the past five years.
Over the last year, Pfizer Inc.'s Net Income growth was (59.3%), which is lower than industry growth of (0.3%). It indicates that Pfizer Inc.'s Net Income growth is Bad.